Kaplan Mehmet, Cimen Serdar, Kut Mustafa Sinan, Demirtas Mahmut Murat
Siyami Ersek Thoracic and Cardiovascular Surgery Center, Istanbul, Turkey.
Heart Surg Forum. 2002;5(1):60-5.
Due to the systemic and hepatic effects of cardiopulmonary bypass (CPB), open-heart surgery for patients with chronic liver disease is associated with high mortality and morbidity. In this retrospective study, we present our results of cardiac surgery on patients with non-cardiac cirrhosis.
Between March 1996 and April 2000, 10 patients with chronic liver disease had open-heart surgery in our institution. Six patients were male and four were female, with a mean age of 57.1 +/- 6.85 years. Preoperative severity of liver disease was determined according to Child classification. Four cases (40%) were Child class A and six (60%) were class B. Coronary artery bypass grafting was performed in four cases, and the remaining six operations were for aortic valve replacement (AVR) and/or mitral valve replacement (MVR). Eight of the operations (80%) were performed by using cardiopulmonary bypass and two (20%) were performed as beating heart surgery.
Chest tube drainage and transfusion needs of these patients were three times the average normal values. Three of the patients for whom CPB was used, all of them in Child class B, died. None of the patients in Child class A died. This resulted in an overall mortality rate of 30%, with mortality of 50% for the Child B group. There was no mortality for any patient who underwent cardiac surgery on the beating heart or cardiac surgery of short duration on CPB. Common characteristics of cases that were associated with high morbidity and mortality included increased postoperative hemorrhagic chest tube output, dependency on mechanical ventilation, hepatic and renal failure, gastrointestinal bleeding, and sepsis. None of the patients died of cardiac failure.
Our findings indicate that cardiac operations may be performed with good results for patients suffering from liver disease of mild severity (Child A), but cardiac interventions that include CPB in conjunction with advanced hepatic pathologies are associated with high mortality and morbidity. Cardiac surgery (whether valvular or coronary artery surgery) for patients with chronic liver disease should be carried out with a short duration of CPB or should be done on the beating heart, if possible, in the case of coronary artery surgery.
由于体外循环(CPB)的全身及肝脏效应,慢性肝病患者的心脏直视手术死亡率和发病率较高。在这项回顾性研究中,我们展示了对非心脏性肝硬化患者进行心脏手术的结果。
1996年3月至2000年4月期间,10例慢性肝病患者在我院接受了心脏直视手术。6例为男性,4例为女性,平均年龄57.1±6.85岁。术前根据Child分级确定肝病严重程度。4例(40%)为Child A级,6例(60%)为B级。4例行冠状动脉旁路移植术,其余6例手术为主动脉瓣置换术(AVR)和/或二尖瓣置换术(MVR)。其中8例手术(80%)采用体外循环,2例(20%)在心脏跳动下进行手术。
这些患者的胸管引流量和输血量是正常平均值的三倍。使用体外循环的3例患者均为Child B级,全部死亡。Child A级患者无一例死亡。总体死亡率为30%,Child B组死亡率为50%。接受心脏跳动下心脏手术或体外循环下短时间心脏手术的患者均无死亡。与高发病率和死亡率相关的病例的共同特征包括术后胸管出血增多、依赖机械通气、肝肾功能衰竭、胃肠道出血和败血症。无一例患者死于心力衰竭。
我们的研究结果表明,对于轻度肝病(Child A级)患者,心脏手术可能取得良好效果,但包括体外循环在内的心脏干预与晚期肝脏病变相关时,死亡率和发病率较高。对于慢性肝病患者的心脏手术(无论是瓣膜手术还是冠状动脉手术),应尽可能缩短体外循环时间,或者在冠状动脉手术的情况下,在心脏跳动下进行手术。